Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation
Considering the essential role of FLT3-ITD mutations in the development of acute myeloid leukemia (AML), the research and development of FLT3 inhibitors hold significant therapeutic potential. In this study, we identified a novel, highly potent small molecule inhibitor, FLIN-4, targeting FLT3 throug...
Saved in:
Main Authors: | Kun Shi, Ye Hong, Huajing Liu, Xiaotian Yang, Fengzhen Wang, Yanming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1511257/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-02-01) -
FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancers
by: Yongchang Tang, et al.
Published: (2025-01-01) -
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01) -
Systematic review and meta-analysis of the impact of abnormal expression of long non coding RNA on the prognosis of acute myeloid leukemia
by: Guihong Liu, et al.
Published: (2025-02-01) -
A Simple Machine Learning-Based Quantitative Structure–Activity Relationship Model for Predicting pIC<sub>50</sub> Inhibition Values of FLT3 Tyrosine Kinase
by: Jackson J. Alcázar, et al.
Published: (2025-01-01)